(Q70997282)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

H P Bhagwatwar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Phadungpojna

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D S Chow

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

B S Andersson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

401-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s002800050404

15 October 2019

exact match

0 references

cites work

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Marrow transplantation following busulfan and cyclophosphamide for chronic myelogenous leukaemia in accelerated or blastic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Measurement of busulfan in plasma by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Pharmacokinetics of high-dose busulfan in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Metabolism of 14C-busulfan in isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Preclinical toxicology and pharmacology of dimethylacetamide, with clinical notes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Efficacy and Toxicity of the Solvent Polyethylene Glycol 400 in Monkey Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050404

Stability-indicating high-performance liquid chromatographic assay of busulfan in aqueous and plasma samples

21 January 2018

1 reference

12 December 2020

Bone marrow transplantation in the busulfan-treated rat. I. Effect of cyclophosphamide and rabbit antirat thymocyte serum as immunosuppression

1 reference

12 December 2020

Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia

1 reference

12 December 2020

A phase I study of dimethylacetamide.

1 reference

12 December 2020

Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia

1 reference

12 December 2020

Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults

1 reference

12 December 2020

Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.

1 reference

12 December 2020

Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia

1 reference

12 December 2020

Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study

1 reference

12 December 2020

Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue

1 reference

12 December 2020

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

1 reference

12 December 2020

Busulfan bioavailability.

1 reference

12 December 2020

Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia

1 reference

12 December 2020

Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan

1 reference

12 December 2020

Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.

1 reference

12 December 2020

High-dose chemotherapy with busulphan and cyclophosphamide and bone-marrow transplantation for drug-sensitive malignancies in adults: a preliminary report

1 reference

12 December 2020

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.

1 reference

12 December 2020

Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection

1 reference

12 December 2020

Chemotherapy of chronic myelocytic leukemia

1 reference

12 December 2020

Lysis of human red blood cells in the presence of various cosolvents

1 reference

12 December 2020

Biliary excretion of a glutathione conjugate of busulfan and 1,4-diiodobutane in the rat

1 reference

12 December 2020

Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy

1 reference

12 December 2020

Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002800050404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8599861%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference